Pregnancy-related Hemophagocytic Lymphohistiocytosis Associated with Herpes Simplex Virus-2 Infection: A Diagnostic Dilemma.
hemophagocytic lymphohistiocytosis; hsv; pregnancy
Hemophagocytic lymphohistiocytosis (HLH) is a severe inflammatory disorder characterized by the uncontrolled proliferation of lymphocytes and histiocytes with hemophagocytic activity in the bone marrow. To our knowledge, there have been a few reported cases of pregnancy-related HLH. This case highlights the importance of considering HLH in a pregnant woman along with other diagnoses, such as HELLP (which stands for hemolysis, elevated liver enzyme levels, and low platelet levels) syndrome and hemolytic anemias. It points to the challenges of diagnosing and managing pregnancy-related HLH due to a similarity in presentation with other conditions.
Nasser M Farhan; Sharma Shorabh; Albers Elizabeth; Sharma Sapna; Duggal Anurag
Cureus
2018
2018-03
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.7759/cureus.2352" target="_blank" rel="noreferrer noopener">10.7759/cureus.2352</a>
Predictors of mortality for nursing home-acquired pneumonia: a systematic review.
80 and over; Aged; Bacterial/*diagnosis/*mortality/therapy; Biological Markers – Therapeutic Use; CINAHL Database; Cross Infection/*diagnosis/*mortality/therapy; Embase; Female; Homes for the Aged/statistics & numerical data; Human; Humans; Incidence; Male; Medline; Meta Analysis; Mortality – Risk Factors; Nursing Care/*statistics & numerical data; Nursing Home Patients; Nursing Homes/*statistics & numerical data; Pneumonia; Pneumonia – Risk Factors; Prognosis; Risk Assessment/methods; Severity of Illness Index; Survival Analysis; Systematic Review; Treatment Outcome
BACKGROUND: Current risk stratification tools, primarily used for CAP, are suboptimal in predicting nursing home acquired pneumonia (NHAP) outcome and mortality. We conducted a systematic review to evaluate current evidence on the usefulness of proposed predictors of NHAP mortality. METHODS: PubMed (MEDLINE), EMBASE, and CINAHL databases were searched for articles published in English between January 1978 and January 2014. The literature search elicited a total of 666 references; 580 were excluded and 20 articles met the inclusion criteria for the final analysis. RESULTS: More studies supported the Pneumonia Severity Index (PSI) as a superior predictor of NHAP severity. Fewer studies suggested CURB-65 and SOAR (especially for the need of ICU care) as useful predictors for NHAP mortality. There is weak evidence for biomarkers like C-reactive protein and copeptin as prognostic tools. CONCLUSION: The evidence supports the use of PSI as the best available indicator while CURB-65 may be an alternative prognostic indicator for NHAP mortality. Overall, due to the paucity of information, biomarkers may not be as effective in this role. Larger prospective studies are needed to establish the most effective predictor(s) or combination scheme to help clinicians in decision-making related to NHAP mortality.
Dhawan Naveen; Pandya Naushira; Khalili Michael; Bautista Manuel; Duggal Anurag; Bahl Jaya; Gupta Vineet
BioMed research international
2015
1905-07
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1155/2015/285983" target="_blank" rel="noreferrer noopener">10.1155/2015/285983</a>